Literature DB >> 7082999

Increased levels of Met-enkephalin-like material in the CSF of anaesthetized cats after tooth pulp stimulation.

F Cesselin, J L Oliveras, S Bourgoin, F Sierralta, R Michelot, J M Besson, M Hamon.   

Abstract

Tooth pulp stimulation in halothane-anaesthetized cats induced a long lasting (greater than or equal to 3 h) increase in the levels of Met-enkephalin-like material (MELM) in the cisternal CSF. Chromatographic analyses (gel filtration, HPLC) revealed that most of the immunoreactivity was attributable to high molecular weight (mol. wt. greater than or equal to 4000) compounds; in non-stimulated cats, Met-enkephalin (largely in the form of the sulfoxide derivative) only accounted for about 10% of total MELM. In contrast, following tooth pulp stimulation, a large increase in Met-enkephalin (plus Met-Ox5-enkephalin) levels was noted so that the pentapeptide thus represented more than 50% of total MELM. No evidence was obtained for the presence of Met-enkephalin-Arg6-Phe7 in the cisternal CSF of halothane-anaesthetized cats. These data strongly suggest that the activity of enkephalinergic neurons was increased following nociceptive stimulation. This indirectly supports the possible physiological role of enkephalinergic systems in modulating nociceptive inputs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082999     DOI: 10.1016/0006-8993(82)90445-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.

Authors:  Elisabeth Bonnard; Hervé Poras; Xavier Nadal; Rafael Maldonado; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  Pharmacol Res Perspect       Date:  2015-01-30

2.  Freezing of enkephalinergic functions by multiple noxious foci: a source of pain sensitization?

Authors:  François Cesselin; Sylvie Bourgoin; Annie Mauborgne; Michel Hamon; Daniel Le Bars
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.